Louisiana Heart Center

Slidell, Louisiana 70458

3 studies enrolling now · 18 studies all time

What they study most

ASCVD, Acute Coronary Syndrome, Acute Myocardial Infarction (AMI), Atherosclerotic Cardiovascular Disease, Atrial Fibrillation, Atrial Flutter, Cardiovascular Disease, Coronary Heart Disease (CHD), Coronary Occlusion, Heart, Heart Failure, Heart Failure With Preserved Ejection Fraction (HFPEF)

Studies at this site

• OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
• AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF — Recruiting now
• A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) — Recruiting now
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity — Completed
• A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Hypertensive Participants With Uncontrolled Blood Pressure — Completed
• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling
• The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) — Stopped early
• GLORIA-AF Registry Program - Second and Third Phases — Completed
• Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• AngelMed for Early Recognition and Treatment of STEMI — Completed
• Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise — Completed
• Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging — Completed